Properties
Description
Imrecoxib blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Formula
C21H23NO3S
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Imrecoxib can be studied for its COX-2 selectivity and the associated anti-inflammatory effects in conditions like arthritis.